News Biomaterials & Biomolecular Systems

  • The Logibody team at the award ceremony.

    Research team mentored by MSB-PI Hendrik Dietz receives m4 Award

    Developing a nanoswitch for antibodies

    25 Oct 2019 | A research team mentored by MSB-PI Hendrik Dietz has received a m4 Award. They have developed a nanoswitch made from DNA that will allow immunotherapies against cancer to target tumors more specifically.

  • Two kinds of nanocompartments with different sizes that contain metal particles and thus can be easily distinguished in an Electron Microscopy. Image: B. van Rossum / FMP

    Shape is the new color

    08 August 2019 | Self-assembling nanoparticles mark cells in electron microscopy.

  • Prof. Oliver Lieleg and PhD student Ceren Kimna use balls and pipe cleaners in different colors to visualize how nanoparticles can be bound together by DNA fragments. Such connections may become the basis of drugs that release their active ingredients in sequence. Image: Uli Benz / TUM

    Artificial DNA can control release of active ingredients from drugs

    01 July 2019 | A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was once a pharmacologist's dream is now much closer to reality. With a combination of hydrogels and artificial DNA, nanoparticles can be released in sequence under conditions similar to those in the human body.

Seite 3 von 3


Zurück zum Forschungsbereich Biomaterialien & Biomolekulare Systeme